APC reacts to a Washington Post report, based on two anonymous sources, that the administration may temporarily allow some restricted peptides while rules are written.
Recap by typeshit. Full story at Alliance for Pharmacy Compounding.
The non-binding vote went against the FDA's own scientists, who opposed every peptide. Six of the eight new panel members run clinics that offer peptides.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Our Peak says skin can lag behind when people lose a lot of weight quickly on GLP-1 drugs, since it needs time to remodel.
Researchers say the experimental drug produced close to three times the weight loss of current options over the same stretch of time.
Loading…